Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. ir. M.H. (Maaike) Oosterveer


Endogenous glucose production in patients with glycogen storage disease type Ia estimated by oral d-[6,6-2H2]-glucose

Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion

Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib (6675 words)

Hyperglycaemia, pregnancy outcomes and maternal metabolic disease risk during pregnancy and lactation in a lean gestational diabetes mouse model

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia

A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: towards glycemic targets

Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a

A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management

Read more


Podcast #4 kweeklever helpt stofwisseling

Academic carreer

Animal Testing